Accès à distance ? S'identifier sur le proxy UCLouvain
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Primary tabs
- Open access
- 2.13 M
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès libre |
Publication date | 2023 |
Language | Anglais |
Journal information | "Multiple sclerosis" - Vol. 29, no. 2, p. 221-235 (2023) |
Peer reviewed | yes |
Publisher | SAGE Publications ((United Kingdom) London) |
issn | 1352-4585 |
e-issn | 1477-0970 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IONS/CEMO - Pôle Cellulaire et moléculaire UCL - (SLuc) Service de neurologie |
MESH Subject | Humans ; Multiple Sclerosis ; Cladribine ; Fingolimod Hydrochloride ; Immunosuppressive Agents ; Dimethyl Fumarate ; Retrospective Studies ; Registries ; Tablets ; Recurrence ; Multiple Sclerosis, Relapsing-Remitting |
Keywords | MS ; disability ; discontinuation ; real-world data ; registry ; relapse ; switching |
Links |
Bibliographic reference | Spelman, Tim ; Ozakbas, Serkan ; Alroughani, Raed ; Terzi, Murat ; Hodgkinson, Suzanne ; et. al. Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.. In: Multiple sclerosis, Vol. 29, no. 2, p. 221-235 (2023) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/276372 |